The relation between Chlamydia pneumoniae and atherosclerosis A causative role of infection in the pathogenesis of atherosclerosis was Further support for a causative role was provided by investigating the relation between C pneumoniae antibody titre and subsequent development of CAD in a nested case-control study of sera collected prospectively from the Helsinki Heart Study.5 Raised IgA titres against Cpneumoniae and the presence of immune-complexes containing C pneumoniae LPS antigen were associated with an increased risk of developing a cardiac event six months later (odds ratio 2-3, 95% confidence interval 1-3 to 5.2). These associations were independent of age, hypertension, and smoking.
In Seattle, USA, investigators showed that in patients undergoing coronary angiography, an increased IgG titre against C pneumoniae (a marker of previous or chronic C pneumoniae infection) was associated with a twofold increase in angiographically detectable CAD. 6 Additionally, our group has recently shown a powerful and-independent association between seropositivity to C pneumoniae (IgG > 1/64) and prevalent CAD in a community cross-sectional survey. 7 Serological studies can be criticised in terms of the controls they used, their borderline statistical significances, and their arbitrarily selected C pneumoniae titre cut-offs for seropositivity. Whether an increased antibody titre is a reliable indicator of underlying C pneumoniae infection or simply a reflection of antigenic cross-reactivity, also remains to be resolved. Nevertheless, several laboratories using different techniques and studying patients in different stages of coronary heart disease, have found a consistent association found between disease and C pneumoniae antibody titres or immune-complexes to C pneumoniae.
Evidence from direct plaque examination C pneumoniae was detected by both the polymerase chain reaction (PCR) and immunohistochemical techniques within coronary atheroma of necropsy specimens from South Africans.8 Of 36 subjects (aged 30-83 years) dying of non-cardiac causes, the organisms were detected in 20 (56%). C pneumoniae was identified within macrophages, the lipid-rich core of atheromatous plaques, and in smooth muscle cells but not in normal tissue adjacent to the sclerotic lesions or in normal coronary arteries from 11 control patients. Lately, similar diagnostic methods detected C pneumoniae in atherectomy specimens from patients with angina9 and from atheromatous arteries in patients with other vascular diseases.'0 Possible mechanisms of damage It remains unclear how C pneumoniae enters atheromatous plaques and whether it has a direct causal role in the atherosclerotic process. C pneumoniae organisms can replicate within alveolar macrophages" and after pulmonary infection may easily gain access to the circulation to spread systemically by being carried by monocytes and macrophages. The organism has been shown to have a ubiquitous extrapulmonary distribution-so far it has been found in arthritic joints'2 and cerebrospinal fluid'3 in addition to atheromatous arteries.8-"0 The consequences of C pneumoniae uptake by macrophages and the mechanisms of damage at the site of the coronary artery remain unknown but there are several possibilities. Firstly, the organism may simply reside in the macrophage without causing any deleterious effects and any association may be purely coincidental (a secondary passenger). Secondly, chronic macrophage infection may contribute to local inflammation and development of atheromatous plaque. This process may be analogous to the pathogenesis of trachoma, where the closely related Chlamydia trachomatis causes blindness as a result of fibrosis which follows conjunctival infiltration by macrophages and lymphocytes. '4 Fibrosis may develop many years after the original infection and represent a hypersensitivity reaction rather than direct effects of the organism itself. Thirdly, C pneumoniae infection may induce a chronic immune activation mediated by cytokines such as IL-1, IL-6, and TNF-alpha that contribute to direct chronic endothelial cell damage or stimulate the synthesis of acute phase proteins such as fibrinogen" and C-reactive protein. '6 It is of interest that a 57 kDa chlamydial heat shock protein (HSP) has been identified and which has close homology with mycobacterial HSP (linked with atherosclerosis'7) and immune crossreactivity could occur. Finally, because C pneumoniae titres show a weak correlation with important procoagulants such as plasma fibrinogen and factor VIIa concentration'5 another possibility is that chronic infection leads to an enhanced procoagulant state with increased risk of coronary thrombosis. This could be mediated by monocytederived procoagulants such as tissue factor,'8 by circulating immune-complexes, or by monocyte-derived cytokines.
Conclusion
A direct role for chronic chlamydial infection in the pathogenesis of CAD is plausible but has yet to be verified. Evidence in support of causation rather than association will only come from prospective vaccination and antibiotic eradication trials. C pneumoniae infection is common and treatable. If 
